Yüklüyor......

Mogamulizumab-kpkc: A Novel Therapy for the Treatment of Cutaneous T-Cell Lymphoma

Mogamulizumab-kpkc provides a novel mechanism of action for the treatment of mycosis fungoides and Sézary syndrome. The efficacy and safety of mogamulizumab-kpkc for the treatment of relapsed or refractory mycosis fungoides and Sézary syndrome were demonstrated in a multicenter, open-label, randomiz...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Adv Pract Oncol
Asıl Yazarlar: Watson, Sutton, Marx, Justin Bradley
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Harborside Press LLC 2019
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7517756/
https://ncbi.nlm.nih.gov/pubmed/33425472
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6004/jadpro.2019.10.8.10
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!